Streptococcus pneumoniae as an agent of nosocomial infection: Treatment in the era of penicillin-resistant strains

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 4, 2001, Pages 34-42

  Paradisi, J ^a   Corti, G ^a   Cinelli, R ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antibiotic therapy; Fluoroquinolones; Multiantibiotic resistance; Nosocomial infection; Oxazolidinones; Penicillin resistance; Streptococcus pneumoniae; Streptogramins; lactams

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC BRONCHITIS; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; NONHUMAN; OTITIS MEDIA; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEIZURE; SINUSITIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035746947     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00056.x     Document Type: Article

References (91)

1. Streptococcus pneumoniae
2. Is Streptococcus pneumoniae a nosocomially acquired pathogen? Infect
3. Antimicrobical treatment guidelines for acute bacterial rhinosinusitis
4. Microbiology of acute and chronic sinusitis in children
5. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: A fifteen-year experience at the University of Virginia and review of other selected studies
6. Otitis media
7. Microbial etiologies of acute otitis media
8. Otitis media in children
9. Acute community-acquired sinusitis
10. Pneumonia in the elderly
11. Epidemiology and treatment of chronic bronchitis and its exacerbations
12. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media
13. Acute bacterial meningitis in adults. A review of 493 episodes
14. Bacterial meningitis in the United States in 1995
15. Acute bacterial meningitis in adults
16. Unusual manifestations of invasive pneumococcal infection
17. An epidemic of cold, bronchitis and pneumonia due to type V pneumococci
18. Pneumococcic pneumonia complicating operations and trauma
19. The causative organisms of septicaemia and their epidemiology
20. Microbiology of nosocomial sinusitis in intensive care unit patients
21. National Nosocomial Infections Surveillance System (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System
22. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
23. Nosocomial pneumococcal pneumonia in the elderly
24. A prospective survey of hospital cross-infection with Streptococcus pneumoniae
25. Report on national survey on infection in hospitals, 1980
26. Bacteriology of hospital-acquired pneumonia
27. Nosocomial pneumococcal bacteremia
28. Comparison of community-acquired and nosocomial pneumococcal bacteremia
29. Microbiological aspects of the 1980 national prevalence survey of infections in hospitals
30. Co-existent cross-infection with Streptococcus pneumoniae and group B streptococci on an adult oncology unit
31. Hospital outbreak of multiresistant Streptococcus pneumoniae
32. A nosocomial outbreak of Streptococcus pneumoniae infection
33. Outbreak of infection with penicillin-resistant Streptococcus pneumoniae in a hospital for the elderly
34. Nosocomial pneumonia in mechanically ventilated adult patients: Epidemiology and prevention in 1996
35. Pneumococcal bacteremia associated with an infected central venous catheter
36. Pneumococcal meningitis resistant to penicillin and nosocomial transmission in pediatric hospitals confirmed by genomic analysis
37. Cross infection with Streptococcus pneumoniae through a resuscitaire
38. Antibiotic resistance in Streptococcus pneumoniae
39. Antibiotic resistance in community-acquired pulmonary pathogens
40. New faces of an old pathogen: Emergence and spread of multidrug-resistant Streptococcus pneumoniae
41. Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media
42. Pneumococcal resistance patterns in Europe
43. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: Multinational study of 917 children with acute otitis media
44. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
45. Antibiotic use and pneumococcal resistance to penicillin: The French experience
46. Pneumococcal pneumonia in adult treated at University of Kentucky Medical Center, 1995-1998: Implications of pathogen resistance
47. Nasopharyngeal carriage of penicillin-resistant S. pneumoniae in daycare centers in Sofia, Bulgaria
48. Modification of prescribers' behavior: The Icelandic approach
49. Carriage and antibiotic resistance of respiratory pathogens and molecular epidemiology of antibiotic-resistant Streptococcus pneumoniae colonizing children in day-care centers in Lisbon: The Portuguese day-care center initiative
50. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
51. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: Findings of a French survey
52. Drug-resistant Streptococcus pneumoniae
53. Infections caused by erythromycin-resistant Streptococcus pneumoniae: Incidence, risk factors, and response to therapy in a prospective study
54. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci
55. Pneumococcal resistance to antibiotics
56. Epidemiology and mechanisms of resistance among respiratory tract pathogens
57. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
58. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program
59. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study
60. Evoluzione delle resistenze ai farmaci antimicrobici in Streptococcus pneumoniae circolante in Italia. Analisi dei dati dell'Osservatorio Epidemiologico Italiano (1998)
61. Resistenza ai farmaci antimicrobici in Streptococcus pneumoniae circolante nel 1999 in Italia
62. Resistance surveillance of Streptococcus pneumoniae. Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998
63. Spread of drug-resistant Streptococcus pneumoniae in Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study
64. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a University hospital in Korea
65. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System
66. Hospital-related outbreak of infection with multidrug-resistant Streptococcus pneumoniae in the Netherlands
67. An outbreak of penicillin resistant Streptococcus pneumoniae investigated by a polymerase chain reaction based genotyping method
68. Nosocomial transmission of penicillin-resistant Streptococcus pneumoniae
69. A hospital outbreak of antibiotic-resistant Streptococcus pneumoniae
70. Clinical significance of pneumococcal bacteremias in a general hospital: A prospective study 1989-1993
71. Treatment of otitis media
72. Therapy of upper respiratory tract infections
73. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group
74. Management of infections due to antibiotic-resistant Streptococcus pneumoniae
75. Treatment options for resistant pneumococcal infections
76. The clinical impact of resistance in the management of pneumococcal disease
77. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae
78. Therapy for pneumococcal infection at the millennium, doubts and certainties
79. The drug-resistant pneumococcus. Clinical relevance, therapy, and prevention
80. In vitro activities of quinolones
81. In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens
82. Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae
83. Gatifloxacin
84. Comparative tolerability of the newer fluoroquinolone antibacterials
85. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin
86. In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae
87. Postantibiotic effect and postantibiotic sub-MIC effect of quinuopristin-dalfopristin against Gram-positive and -negative organisms
88. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic
89. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae
90. Pneumococcal vaccines: History, current status and future directions